Tumor
7 articles · search the full text for this term
-
Drugs Design and Process Chemistry: A Factuality Study of Recent Advance in Drug Delivery Systems – A Comprehensive Review
Abstract: Recent years have seen significant advances in drug design and process chemistry, mostly due to breakthroughs in drug delivery technologies. This study provides a thorough examination of current developments in drug delivery, emphasizing strategies that improve therapeutic efficacy, reduce adverse effects, and maximize pharmacokinetic profile. The effects of several strategies on drug stability, solubility, and bioavailability are examined, including controlled-release systems, targeted delivery methods, and nanoparticle-based delivery. This review also …
Published in Research and Reviews : A Journal of Biotechnology · Vol. 15, Issue 1, 2025 · pp. 26–35 Read article
-
Current Drugs Target the EGFR
Abstract: Cancer is a devastating disease, but there have recently been significant advancements in therapy that have identified EGFR and its related proteins as valuable indicators and targets for treatment. The ERBB receptor tyrosine kinase superfamily includes EGFR, which is a transmembrane glycoprotein. When the EGFR receptor interacts to its particular ligand, EGF, it causes tyrosine residues to be phosphorylated and forms receptor dimers with other members of the receptor family. …
Published in Research and Reviews : A Journal of Medical Science and Technology · Vol. 13, Issue 2, 2024 · pp. 1–8 Read article
-
Hidradenocarcinoma: A Rare Skin Disease
Abstract: Hidradenocarcinoma (HAC) also known as ‘‘sweat gland tumor” is an aggressive, uncommon, highly malignant, adnexal tumor derived from the intradermal duct of eccrine sweat glands. It is said to be aggressive as it has a high risk of local recurrence (50%–75%) and a high potential to metastasize to nearby lymph nodes or to other distant sites. Hidradenocarcinoma has other recognized variants which are known by different names such as Malignant …
Published in International Journal of Cell Biology and Cellular Functions · Vol. 2, Issue 1, 2024 · pp. 1–12 Read article
-
AWARENESS REGARDING PROTON THERAPY AMONG NURSES
Abstract: Background: Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. The most common cancers are breast, lung, colon and rectum and prostate cancers. [1] Proton beam therapy, is a type of radiation treatment that uses a beam of protons to deliver radiation directly to the tumor. The advantage of proton therapy is that the physician can control …
Published in Research and Reviews: Journal of Oncology and Hematology · Vol. 12, Issue 3, 2023 · pp. 19–23 Read article
-
Development of Intensity-based Segmentation Technique for Meningioma Tumor Detection in MRI Images
Abstract: There are many types of brain tumors. Some brain tumors detection system using segmentation and classification of MRI images. Brain tumors can have any shape or cut. This encourages us to use high-capacity deep neural networks. Segmentation task and 8000 images for classification task of our neural network and found the best architecture to use. convolutional neural network. In recent years, the three most common forms of brain tumours—glioma, meningioma, …
Published in Research and Reviews : Journal of Computational Biology · Vol. 11, Issue 03, 2022 · pp. 50–54 Read article
-
The Effect of Prepared Biochemical Compounds on Cancer Cells
Abstract: The effect of prepared biochemical compounds affecting cancer cells, where the chemical compounds are divided into two parts, some of which are treatment for cancerous tumors, and others activate cancer cells such as glucose and sugars, which increase the size of the cancerous tumor and its spread in the body. While chemotherapy usually refers to the use of antitumor drugs to treat cancer through a cytotoxic treatment method. It also …
Published in Research and Reviews: Journal of Oncology and Hematology · Vol. 11, Issue 1, 2022 · pp. 14–20 Read article
-
Chemical Causes of Leukemia
Abstract: Leukemia was first described by the French physician and surgeon Alfred-Armand-Louis-Marie-Villebeau in 1827. This review talks about Pathologist Rudolf Virchow that gave a more comprehensivedescription in 1845. After Virchow saw a high number of white blood cells in a sample of a patient'sblood The deceased leukemia patient was "dirty green-yellow" rather than the normal red. Neumannconcluded from here that a problem in the bone marrow is responsible for the abnormal …
Published in Journal of Modern Chemistry & Chemical Technology · Vol. 12, Issue 3, 2021 · pp. 25–36 Read article